Company / Return on Equity (ROE)
Alkermes plc Return on Equity (ROE) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
13.3%
FY2025
5-year range
-15.2% / 29.6%
FY2021-FY2025
Trend
-47.0%
vs FY2024
Sector context
#32 of 190
Health Care
What the data says
Alkermes plc's return on equity (roe) of 13.3% is higher than 83% of companies in the Health Care sector (FY2025). Return on Equity (ROE) has fluctuated over the past 10 years, ranging from -18.1% in FY2019 to 29.6% in FY2023.
Based on SEC 10-K filings.
13.3% in FY2025 with a 5-year CAGR of +23.7%. Top quartile in the Health Care sector.
Declined from 29.6% to 13.3% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +28.4pp
- 5-Year Change
- +23.7pp
- 10-Year Change
- -
Sector benchmark
+126.4% above sector average
Key checks
Key Insights
- In FY2025, return on equity (roe) decreased 47.0% year-over-year.
- Currently 63.6pp above the Health Care sector average.
- Peak return on equity (roe) was recorded in FY2023.
- Lowest return on equity (roe) in the period was in FY2019.
Company context
Key Data Points
- Strong profit margin: 22.3%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 13.3% | -47.0% |
| FY2024 | 25.1% | -15.3% |
| FY2023 | 29.6% | +295.1% |
| FY2022 | -15.2% | -250.1% |
| FY2021 | -4.3% | +58.3% |
| FY2020 | -10.4% | +42.6% |
| FY2019 | -18.1% | -52.3% |
| FY2018 | -11.9% | +9.4% |
| FY2017 | -13.1% | +23.8% |
| FY2016 | -17.2% | -1138.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026